港股異動 | 匯量科技(1860.HK)大漲超11% 獲多家機構看好
格隆匯6月10日丨匯量科技(1860.HK)現報9.01港元,大漲11.37%,暫成交9637萬港元,最新市值144億港元。瑞銀最新發研報指,市場低估了匯量科技旗下平台Mintegral於2021至2022年度潛在增長趨勢,且公司於第二及三季盈利有望獲重新評級,因此重申其“買入”評級。該行對Mintegral長線前景感到樂觀,相信受惠於遊戲內廣吿行業的增長,維持其今年度每股盈利預測,但上調明年盈測8%,目標價由9.5港元升至12.5港元。招銀國際亦指,作為全球領先的移動廣吿分析平台,匯量科技有望受益於應用程序全球化和SaaS發展帶來的蓬勃廣吿需求;給予公司買入評級,基於DCF的目標價為11.1港元。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.